Speech-Based Prediction for Psychotic Relapse

Predicting Psychotic Relapse Using Speech-Based Early Detection

Recruiting Observational Study
Psychosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 and older
Sex
Any
Study type
Observational
Participants needed
250 (estimated)
Sponsor
Douglas Mental Health University Institute · Other
Who this trial is looking for

This trial is looking for people aged 16 and older who have been diagnosed with a psychotic disorder like schizophrenia. Participants will be involved in a research program that uses speech to help predict relapses in their condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 16 years or older
  • I have been diagnosed with a psychotic disorder
  • I speak English or French
  • I am currently receiving treatment through an Early Psychosis Intervention program

You may not be able to join if

  • I have a severe speech or language disorder
  • I have a non-psychotic disorder as my main diagnosis
  • I cannot give consent or take part in assessments

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Psychotic disorders, including schizophrenia and affective psychosis, are severe mental health conditions marked by recurrent episodes that contribute to long-term disability. Relapses, characterized by the re-emergence of psychotic symptoms after remission, are a critical factor in the progression of these disorders, increasing risks such as suicide, cognitive impairment, and unemployment. This s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age must be 16 years and older * Diagnosis must meet DSM-5 criteria for psychotic disorders, including schizophrenia, schizoaffective disorder, or related conditions * Fluency in English or French * Must be currently receiving treatment through an EPI program Exclusion Criter…
Contacts

Lena Palaniyappan, MD, PHD

5147616131

lena.palaniyappan@mcgill.ca

CONTACT